Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product ...

Interruptions, to-do lists, lack of autonomy — “time poverty” depends more on perceived shortages of time than actual ones, recent research suggests.

Staying focused is becoming harder than ever in the modern world of constant emails, phone alerts, and multitasking. Many ...

In this excerpt from the new book 'Speak Data,' the Wharton professor and best-selling author shares his thoughts on how we ...